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Abstract
Background: Behavioural and psychological symptoms are associated with dementia, but are also present in a
significant number of the older population without dementia. Here we explore the distribution of behavioural and
psychological symptoms in the population without dementia, and their relationship with domains and severity of
health and cognitive impairment.
Methods: The Medical Research Council Cognitive Function and Ageing Study is a two-phase longitudinal study of
ageing representative of the population aged 65 and over of England and Wales. A subsample of 1781 participants
without a study diagnosis of dementia was included in this study. Information on symptoms including depression,
apathy, anxiety, feelings of persecution, hallucination, agitated behaviour, elation, irritability, sleep problems,
wandering, confabulation and misidentification, cognitive function, health related factors and socio-demographic
information was extracted from interviews with participants and knowledgeable informants. Participants were
classified according to the Mini-Mental State Examination and by criteria for subtypes of mild cognitive impairment
(MCI). The prevalence of behavioural and psychological symptoms and associations with cognitive function, health
and socio-demographics was examined. Co-occurrence of symptoms was tested using factor analysis.
Results: Most symptoms were reported more frequently in those with more severe cognitive impairment.
Subjective memory complaints were the strongest independent predictor of reported symptoms, and most were
reported more often in those classified as having MCI than in those with cognitive impairments that did not meet
the MCI criteria. The pattern of co-occurrence of symptoms is similar to that seen in dementia.
Conclusions: Our results highlight that behavioural and psychological symptoms are prevalent in the cognitively
impaired older population, and partly explain the variation observed in previous cohorts of individuals with MCI.
Behavioural and psychological symptoms offer a target for intervention and so are an important consideration in
the assessment of cognitively impaired older people.
Background
Behavioural and psychological symptoms are common
in dementia. These symptoms include depression and
anxiety, psychotic symptoms, wandering, agitated beha-
viour and sleep disorders, and are collectively known as
the behavioural and psychological symptoms of demen-
tia (BPSD). These symptoms confer a large proportion
of the social burden of dementia [1,2], and are impor-
tant targets for intervention in dementia patients [3].
Yet these symptoms are not restricted to those with
dementia. Many behavioural and psychological problems
are also present in a significant proportion of the
non-demented older population [4,5]. Behavioural and
psychological symptoms have been associated with cog-
nitive impairments not sufficient for a diagnosis of
dementia, although their prevalence and relationship to
cognitive impairments are not clear. Two recent reviews
have highlighted the variation in estimates of the
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prevalence of behavioural and psychological symptoms
in those with mild cognitive impairment (MCI) and sug-
gested that differences in the settings of studies, the
characteristics of participant groups, and the definitions
of symptoms and of MCI contribute to this variation
[6,7]. We have previously compared the prevalence of
BPSD in the older population with and without demen-
tia [4]. In this article we use data from the population-
representative Medical Research Council Cognitive
Function and Ageing Study (MRC CFAS) to explore the
relationship between behavioural and psychological
symptoms with the socio-demographic, health and cog-
nitive factors that are used to define different classifica-
tions of MCI.
Methods
Study participants
The Medical Research Council Cognitive Function and
Ageing Study (MRC CFAS), is a multi-centre longitudinal
study that is fully described elsewhere [8]. Between 1990
and 1991 a random sample of individuals aged 65 years
and older living in five centres representative of rural
and urban areas in England and Wales (Cambridgeshire,
Gwynedd, Newcastle, Nottingham and Oxford) were
contacted, with a response rate of 82%. At baseline, 13,004
participants completed the screening interview. A sub-
group of those screened including all participants with
severe cognitive impairments and a stratified subsample of
the remainder (n = 2640) also completed a more detailed
assessment. This included selected items from the Geriatric
Mental State Automated Geriatric Examination for Com-
puter Assisted Taxonomy (GMS-AGECAT), Mini Mental
State Examination (MMSE) [9] and the multi-domain
Cambridge Cognitive Examination (CAMCOG) [10].
Persons diagnosed with dementia (defined as an AGE-
CAT organicity rating case level of O3 or above, n =
587 [11]), an unknown dementia status (n = 3), a
MMSE score that is missing or below 18 (n = 243), or
Parkinson’s disease (n = 26) were excluded. Therefore of
the 2640 who undertook the assessment interview 1781
persons were included in this study. The aim of this
study was to analyse the psychiatric correlates of cogni-
tive impairment, and so those with underlying psychia-
tric conditions were not excluded from the study.
Informed Consent and Confidentiality
MRC CFAS has Multi-centre Research Ethics Committee’s
approval and ethical approval from the relevant local
research ethics committees. All participants gave informed
consent and patient confidentiality was not breached.
Assessment of behavioural and psychological symptoms
Symptoms assessed during the screen, assessment and
informant interviews include depression, apathy, anxiety,
feelings of persecution, hallucination, agitated behaviour,
elation, irritability, sleep problems, wandering, confabu-
lation and misidentification. Symptoms were assessed
using interviews conducted with both study participants
and their informants, combined with observations made
by the interviewer during the course of the interviews.
Depression was measured with the Cambridge Mental
Disorders of the Elderly Examination (CAMDEX) [12].
Details of the questions used to assess each symptom
have been described previously [4].
Assessment of cognitive function and definition for ‘mild
cognitive impairment’ criteria
Cognitive function was assessed using the MMSE [9]
and by classification based on definitions of mild cogni-
tive impairment (MCI) and its subtypes [13]. Using the
MMSE, cognitive function was classified as low (18-21),
intermediate (22-25) or high (26-30). Classifications of
MCI aim to identify individuals with cognitive impair-
ments likely to indicate incipient dementia. Three sub-
types are considered, amnestic (A-MCI) including
deficits in memory, non-amnestic (N-MCI) in which
cognitive impairment is restricted to non-memory
domains and multiple (M-MCI) in which both memory
and non-memory domains of cognition are impaired
[13].
A clinical diagnosis of MCI requires a subjective com-
plaint of memory impairment by either the respondent
themselves or an informant. Performance on cognitive
tests must fall below a specific threshold, typically below
1 or 1.5 standard deviations of the mean age-specific
performance, or if test scores are highly skewed below
the 16th or 7th percentiles. To exclude those with possi-
ble dementia, general cognitive function must not be
severely impaired. Exclusion criteria can include any
health or psychiatric problems that might be the alter-
native cause of cognitive impairment, or a severe
impairment in activities of daily living. The operationali-
sation of these criteria, including the level of subjective
memory complaint, the specific cognitive tests and exact
exclusion criteria, are not specified.
For the present study, ‘subjective memory complaint’
was defined as a report of memory problems by either
the respondent or an informant at either the screening
or the assessment interview. ‘Objective memory impair-
ment’ was defined using as a score below the 16th age-
specific percentile on one or more of the remote mem-
ory, recent memory or learning memory domains of the
CAMCOG. ‘Non-memory impairment’ was defined
using as a score of below the 16th age-specific percentile
on any of the other cognitive domains measured by
CAMCOG which includes orientation, language, atten-
tion/calculation, praxis, abstract thinking or perception.
CAMCOG cut-off scores were age adjusted using five
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5-year age groups including 65-69, 70-74, 75-79, 80-84
and 85+ years. General cognitive function was deemed
to be severely impaired when participants scored less
than 22 on MMSE. No health-related or functional
exclusions were applied, since the relationships between
these and behavioural and psychological symptoms were
of interest in the present study.
MCI subtypes were assigned as follows: All MCI sub-
types required subjective memory complaint and no
severe impairment of general cognitive function (ie
MMSE > = 22). Those with memory impairment but no
non-memory impairment were classified as A-MCI.
Those with non-memory impairment but no memory
impairment were classified as N-MCI. Those with
impairments in memory and non-memory domains
were classified as M-MCI. Participants were not
excluded on the basis of medical or psychiatric pro-
blems. Full details of the mapping of MCI in MRC
CFAS have been published elsewhere [14].
A ‘not impaired’ group was defined using the following
criteria: normal general cognitive function, no severe func-
tional impairment, normal memory and non-memory test
performance. Participants who could not be classified as
“not impaired” or MCI using any definition were classified
as “other cognitive impairment, no dementia” (OCIND).
This heterogeneous group includes both respondents with
an objective memory impairment but no subjective mem-
ory complaint, and those with impaired general cognitive
function but not diagnosed with dementia.
Covariates
As well as those factors that contribute to the definition of
MCI, other factors considered in our analysis included sex,
age, institutionalization, vascular co-morbidity, education,
and social class. Age was reported continuously as well as
being dichotomized into 65-74 years versus 75 years and
older. Vascular co-morbidity was defined using self or
informant reported history of a heart attack, stroke or dia-
betes. Institutionalisation was divided into two groups
including, independent (living alone or in a warden con-
trolled flat) or dependent (living in a residential home, nur-
sing home or hospital). Level of education was measured in
number of years of education and was divided into two
groups including less than 10 years and 10 or more years
of education. Functional impairment was defined as requir-
ing help at least several times per week with activities of
daily living (ADLs) such as washing, cooking for them-
selves, dressing, or if the respondent was housebound.
Data were missing in fewer than 2% of individuals for each
covariate and was assumed to be missing at random.
Statistical analysis
All analyses were performed using Stata 10.0. The pre-
valence of each behavioural and psychiatric symptom
was estimated in cognitive groups. Participants were
grouped both by MMSE scores, and by MCI classifica-
tion. Three MMSE categories were defined including
low (18-21), mild (22-25) and high (26-30). MCI classifi-
cations were ‘not cognitively impaired’, ‘MCI’ and
‘OCIND’. Prevalences were also compared across MCI
subgroups A-MCI, N-MCI and M-MCI as previously
described. Differences in prevalence across groups were
tested using likelihood ratio tests. Post-hoc pairwise
tests comparing subgroups were not conducted.
Participants were back-weighted in prevalence estima-
tion to adjust for over-sampling in the study population
of individuals aged 75 years or older and the subsequent
stratified sampling for the assessment interview. The
relation between symptoms, subjective memory com-
plaint, objective memory impairment, vascular disease,
disability and socio-demographic factors was investi-
gated using both univariate and multivariate logistic
regression.
Co-occurrence between symptoms was measured
using odds ratios estimated using logistic regression.
Univariate analyses and multivariate analyses adjusting
for the presence of all other symptoms, MMSE, age and
sex were conducted. Factor analysis was used to deter-
mine the structure of the co-occurrence of symptoms.
The Spearman’s correlation matrix relating the symp-
toms was estimated and this was subjected to the princi-
ple factor analysis algorithm. The resulting factor
solution was rotated for ease of interpretation using the
Varimax rotation. This factor analysis was repeated
within each of the MMSE and MCI subgroups described
above.
Results
Characteristics of study participants
Table 1 shows the characteristics of the study partici-
pants stratified by MCI classification. The age of all
three groups was similar, but women were more likely
to be cognitively impaired. Few individuals were living
in institutions. Those without cognitive impairments
were substantially more likely to be better educated and
in a higher social class, and to have better self rated
health. The proportion of participants with reported vas-
cular disease was similar across groups. The OCIND
group had lower cognitive function than the MCI group
or the NCI group, and a lower prevalence of impair-
ments in ADLs. The OCIND group reported most fre-
quent use of anti-psychotic medication, while the MCI
group had greater reported use of anti-depressants.
Prevalence of symptoms across MMSE cognitive
classifications
The prevalence of each behavioural and psychological
symptom by MMSE group and MCI classification is
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shown in table 2. The previously reported prevalence in
those with dementia is also shown for comparison. The
prevalence of many symptoms was higher in those with
worse cognition.
There was a statistically significant trend to increased
depression, apathy, psychosis, agitation, and irritability
in those with worse cognition. Inappropriate elation,
wandering and confabulation were rare in this sample
making differences between groups difficult to detect,
nevertheless there is some evidence that each of these is
more common in those with worse cognition. Sleep pro-
blems were common and reported with equal frequency
across MMSE groups. There was no significant differ-
ence in the prevalence of anxiety across cognitive
groups.
Prevalence across MCI classifications
Significant differences in the prevalence of depression,
apathy, persecution and irritability were seen across
MCI groups, with the prevalence of each of these lowest
in those without cognitive impairment. Sleep problems
were reported least often in the OCIND group (38.6%),
and most often in the MCI group (49%). Wandering
and confabulation were rarely reported in this sample
with little evidence of a difference across groups. Hallu-
cinations, agitated behaviour and anxiety were seen least
often in those with no impairment and most often in
MCI, but these differences were not statistically signifi-
cant. There was little difference in the prevalence of
misidentification across groups.
Cognitive function was higher in the A-MCI group
(mean MMSE = 26.3) than in the N-MCI (mean MMSE
= 25.3) and M-MCI (mean MMSE = 24.5) groups
(F(2,387) = 10.91:p < 0.001). The only statistically signif-
icant differences in symptom prevalence observed across
MCI subgroups were a high prevalence of elation in
A-MCI and a higher prevalence of hallucinations in
those with memory impairments (ie M-MCI and
A-MCI). There is some evidence that depression and
apathy are more common in those with non-memory
impairments (N-MCI and M-MCI) with anxiety more
common in those with memory impairments. Feelings
of persecution and sleep problems were equally com-
mon across all groups.
Effects of health-related, sociodemographic and cognitive
characteristics on presence of symptoms
In univariate analyses (additional file 1: table S1) mem-
ory impairment, subjective memory complaint, ADL
impairment, and lower MMSE score were associated
with higher prevalence of many symptoms. Vascular
comorbidity is associated with an increased risk of
symptoms of mood including depression, anxiety, apathy
and irritability.
After adjustment for all other risk factors (additional
file 2: table S2) the effect of objective memory impair-
ment and of MMSE score is largely attenuated, while
the presence of subjective memory complaint remains
associated with the presence of many symptoms. The
association between vascular disease with depression,
apathy, anxiety and irritability remains although strength
is reduced.
Many symptoms appear less common in older people
in multivariate analyses, suggesting younger people with
lower cognition were more at risk of BPSD than older
people. Depression and sleep problems are more fre-
quently reported in women, while apathy is more com-
mon in men. There is a non-significant increase in
other symptoms in women, which remains in multivari-
ate analyses.
Co-occurrence of symptoms
Table S3 in additional file 3 shows univariate and multi-
variate pairwise associations between symptoms. There are
many significant associations between pairs of symptoms
which remain after adjusting for the presence of all other
Table 1 Characteristics of the population by MCI classification
No Cognitive Impairment MCI OCIND
Age mean(se) 73.5 (0.28) 73.8 (0.43) 73.5 (0.31)
MMSE mean(se) 27.4 (0.08) 25.4 (0.14) 24.4 (0.18)
Female N(%) 389 (58) 242 (62) 439 (65)
Living in institutions N(%) 8 (1.2) 11 (2.8) 23 (3.4)
Vascular disease N(%) 134 (20) 111 (29) 164 (24)
Taking anti-depressant medication 20 (3.0) 23 (5.9) 29 (4.3)
Taking anti-psychotic medication 2 (0.3) 1 (0.3) 5 (0.7)
Impaired activities of daily living N(%) 66 (10) 69 (18) 140 (21)
More than 9 years education N(%) 310 (46) 108 (28) 153 (23)
Regular contact with family N(%) 374 (73) 222 (83) 397 (79)
Poor self-rated health N(%) 178 (27) 168 (44) 256 (38)
Lower social class N(%) 365 (54) 278 (71) 493 (73)
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symptoms, MMSE, age and sex. Factor analysis (table 3)
suggests three factors arising from this observed co-occur-
rence. The three factor solution included: (a) symptoms of
hallucination and misidentification, (b) symptoms of anxi-
ety, apathy and depression and (c) irritability, persecution
and wandering. The fourth strongest factor does not
include any symptoms with loading greater than 0.3. How-
ever the uniqueness of each symptom was high, suggesting
that much of the variability of each symptom cannot be
explained by this factor model, and there are many
Table 2 Prevalence of symptoms across cognitive groups
MMSE 18-21
(N = 316)
MMSE 22-25
(N = 659)
MMSE 26-30
(N = 806) p-value
All without
dementia or
severe cognitive impairment
(N = 1781)
Depression 58 (17.6) 67 (8.3) 73 (7.4) 0.001 198 (8.4)
Apathy 78 (25.2) 98 (13.5) 88 (9.6) 0.000 264 (11.8)
Anxiety 22 (7.2) 29 (4.0) 56 (6.7) 0.147 107 (6.0)
Persecution 44 (12.7) 76 (9.5) 61 (6.8) 0.012 181 (8.0)
Hallucinations 24 (6.7) 27 (3.0) 29 (3.4) 0.046 80 (3.5)
Agitation 23 (7.5) 28 (3.6) 28 (2.9) 0.013 79 (3.4)
Elation 18 (4.7) 20 (2.8) 29 (3.1) 0.252 67 (3.2)
Irritability 61 (17.4) 107 (14.6) 93 (10.8) 0.021 261 (12.3)
Sleep problems 131 (40.3) 302 (45.4) 360 (42.4) 0.366 793 (43.0)
Wandering 3 (0.6) 5 (0.4) 3 (0.2) 0.817 11 (0.3)
Confabulation 2 (0.6) 3 (0.2) 2 (0.1) 0.734 7 (0.2)
Misidentification 18 (6.5) 20 (2.9) 19 (2.8) 0.219 57 (3.1)
No Cognitive Impairment
(N = 670)
All MCI
(N = 389)
OCIND
(N = 676) p-value
Dementia
(Savva et al 2009[4])
Depression 48 (6.0) 61 (14.5) 79 (8.5) 0.002 20.5
Apathy 67 (9.0) 79 (17.8) 110 (13.1) 0.004 50.3
Anxiety 35 (5.4) 33 (8.0) 36 (5.9) 0.427 8.9
Persecution 41 (5.5) 61 (13.5) 76 (9.3) 0.001 25.4
Hallucinations 17 (2.3) 25 (5.2) 34 (4.3) 0.148 15.1
Agitation 20 (2.6) 20 (5.2) 37 (3.9) 0.228 9.0
Elation 21 (2.8) 17 (5.0) 27 (2.6) 0.221 9.5
Irritability 73 (10.5) 82 (17.4) 100 (12.6) 0.041 28.8
Sleep problems 297 (43.0) 198 (49.0) 276 (38.6) 0.036 42.0
Wandering 2 (0.3) 4 (0.4) 3 (0.2) 0.665 12.8
Confabulation 2 (0.1) 2 (0.2) 3 (0.3) 0.483 5.8
Misidentification 22 (3.5) 12 (2.4) 21 (2.4) 0.524 20.3
Amnestic MCI
(N = 75)
Non-amnestic MCI
(N = 185)
Multiple MCI
(N = 129) p-value
Depression 7 (9.3) 29 (14.8) 25 (18.7) 0.586
Apathy 11 (10.8) 34 (17.9) 34 (23.8) 0.202
Anxiety 7 (12.2) 12 (5.6) 14 (9.2) 0.374
Persecution 10 (12.7) 25 (12.3) 26 (16.9) 0.723
Hallucinations 5 (7.6) 10 (2.4) 10 (8.8) 0.042
Agitation 1 (2.9) 10 (5.5) 9 (6.4) 0.807
Elation 5 (12.7) 7 (3.0) 5 (2.2) 0.011
Irritability 20 (24.7) 35 (15.8) 27 (14.0) 0.240
Sleep problems 31 (44.1) 97 (48.5) 70 (54.3) 0.649
Wandering 1 (0.4) 1 (0.2) 2 (0.8) 0.682
Confabulation 1 (0.7) 0 (0.0) 1 (0.2) 0.603
Misidentification 3 (3.6) 6 (1.5) 3 (3.4) 0.496
Prevalence of symptoms N(%) across MMSE groups (top) MCI classification (middle) and MCI subtypes (bottom). All percentages are back-weighted to the
population. P-values correspond to a likelihood ratio test of differences across groups.
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statistically significant pairwise associations between
symptoms that the factor model does not include (supp
table 3). The factor structure is largely consistent across
cognitive and MCI groups (table 4) and is similar although
with weaker associations to that seen in the population
with dementia [4].
Discussion
Summary of findings
In this large, representative study of the population
without dementia or severe cognitive impairment we
have reported the prevalence of behavioural and psycho-
logical symptoms, and the relationship between such
symptoms and aspects of cognitive impairment, adjust-
ing for a wide range of sociodemographic and health
related risk factors. The prevalence of many symptoms
increases with worsening cognition, the presence of a
subjective memory complaint and impaired functional
ability. Depression, anxiety and apathy were more com-
mon in those with a history of vascular disease whereas
agitated behaviour is more common in those without.
Many symptoms were reported more frequently by
those with MCI than by those who were cognitively
impaired without meeting the definition of MCI (the
OCIND group), the majority of who failed to meet the cri-
teria for MCI owing to the absence of a subjective memory
complaint. Within the MCI group, those without memory
impairments (N-MCI) typically suffered fewer symptoms
than those with only memory (A-MCI) or with memory
and non-memory cognitive impairment (M-MCI). How-
ever, in multivariate analysis adjusting for subjective mem-
ory complaint and cognitive function, those with an
objective memory disorder were not found to be at higher
risk. Age and sex also affected the prevalence of psychia-
tric conditions, with depression more common in women
and in those under 75 years of age, while apathy was more
frequently reported in men, echoing our earlier findings in
the population with dementia [4]
Strengths and limitations of the study
We assessed the prevalence of behavioural and psycho-
logical symptoms with respect to a wide variety of
socio-demographic, cognitive and health-related factors,
allowing a detailed investigation of the associations
between symptoms and the factors that comprise the
definitions of MCI. Our assessment of symptoms has
been previously used to report the prevalence and corre-
lates of behavioural and psychological symptoms of
dementia in demented and non demented groups, how-
ever it is difficult to compare prevalences of symptoms
here with those reported using the informant based
Neuropsychiatric Inventory (NPI) [15]. Our study was
Table 3 Factor analysis of association between
behavioural and psychological symptoms in the
population without dementia
Symptom Factor1 Factor2 Factor 3 Factor 4 Uniqueness
Agitation -0.03 0.06 -0.02 0.16 0.96
Anxiety 0.11 0.40 0.01 -0.02 0.83
Apathy 0.14 0.33 0.18 0.02 0.84
Confabulation -0.04 0.10 0.02 -0.05 0.97
Depression 0.22 0.42 0.11 0.02 0.76
Elation 0.17 0.00 0.22 0.21 0.88
Hallucinations 0.53 0.08 0.11 0.03 0.70
Irritability 0.08 0.18 0.39 -0.01 0.81
Misidentification 0.49 0.12 0.00 -0.01 0.74
Persecution 0.07 0.09 0.42 0.01 0.81
Sleep problems -0.01 0.17 0.11 0.09 0.95
Wandering 0.18 -0.06 0.32 0.11 0.85
Factor loadings > 0.3 are shown in bold.
Table 4 Factor structure representing the relationships between behavioural and psychological symptoms by
cognitive classification
MMSE groups Factor 1 Factor 2 Factor 3 Factor 4
MMSE 18-21 mis/hal/wan/ela apa/mis/anx/dep per/irr
MMSE 22-25 mis/hal apa/anx/dep per/irr
MMSE 26-30 mis/hal anx/dep/(apa) per/wan/irr
MCI classification
Normal mis/hal anx/dep per/wan/irr
MCI mis/hal apa/anx/dep/sle per/wan/ela/irr
OCIND mis/hal apa/anx/dep per/irr wan/(ela)
MCI Subtypes
A-MCI mis/hal apa/anx/dep/sle per/wan/ela/irr agi/irr
N-MCI mis/hal/anx/dep apa/sle per/irr ela/agi
M-MCI mis/hal/wan/ela apa/anx/dep irr/(per)
Dementia (adapted from Savva et al 2009 [4]) mis/hal/con/apa/per/wan anx/dep/hal irr/per/agi agi/ela/hal/sle/wan
Symptoms are included in each factor if their factor loading is >0.3 (symptoms loading >0.25 but <0.3 are shown in brackets). Key to symptoms: mis =
misidentification, hal = hallucinations, wan = wandering, ela = elation, apa = apathy, anx = anxiety, dep = depression, per = feeling of persecution, irr =
irritability, agi = agitated behaviour, sle = sleep problems.
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population-based and our estimates were therefore not
biased by referral filters. Prevalences were backweighted
to account for the study design being representative of
the older population of England and Wales without
dementia. Symptoms were assessed using interviews
conducted with both study participants and their carers,
combined with observations made by the interviewer
during the course of the interviews. However, neither
the severity of symptoms nor the extent to which they
were problematic to participants was recorded.
Wandering and confabulation were rare in the non-
demented sample and very few individuals lived in insti-
tutions making associations between these and other
factors difficult to detect. Although the response rate of
the study is high at 82%, variables were missing for
some subjects. The primary cause of a missing MMSE
score in our study is severe cognitive impairment and
we excluded individuals with missing MMSE from this
investigation. Symptom presence was determined on the
basis of any evidence being present from screen or
assessment interviews. Where no evidence was present,
symptoms were assumed to be absent. Covariate data
were missing in only a small proportion of cases and
where missing were assumed to be missing at random.
Depression
Depression has a complex relationship with dementia
and cognitive impairment [16]. It is known that depres-
sion is a risk factor for dementia [17], but also that
depression is a direct cause of cognitive impairment that
may not indicate incipient dementia [18]. Depression is
further acknowledged as a symptom of dementia with a
high incidence in the early stages of dementia [4].
Depression is the most commonly studied non-cognitive
correlate of MCI, with estimates of the prevalence of
depressive symptoms ranging from 16-40% in popula-
tion based studies [6]. The varying instruments and
threshold for assessment of depression make cross study
comparison difficult. The population based Three-City
Study found that 16% of 2879 individuals with MCI had
some depressive symptoms, 9.2% sub-threshold depres-
sion and 2.4% had DSM-IV clinical depression [19]. We
found depression to be most common in those with the
lowest MMSE scores (17.6%) and more common in
MCI (14.5%) than in those with no cognitive impair-
ment (6%) or other cognitive impairments (8.5%).
Relationship between behavioural and psychological
symptoms with cognitive impairment
A subjective memory complaint is the strongest indepen-
dent predictor of reported symptoms in multivariate ana-
lyses. This might be explained by behavioural and
psychological symptoms causing memory impairments to
be noticed, or a generally high awareness of both cognitive
and non-cognitive symptoms. Subjective memory com-
plaints are commonly reported by older people, although
previous studies have shown depression to be a stronger
predictor of subjective memory complaint than objective
cognitive impairments [20]. Subjective memory complaints
are required for a clinical diagnosis of MCI, and so those
diagnosed with MCI are more likely to report behavioural
and psychological symptoms than those who are similarly
cognitively impaired in the population.
We found objective memory impairment to be asso-
ciated with many symptoms in univariate analysis, and
some evidence for differing symptom profiles across MCI
subtypes, although the power to detect these differences
was limited. Hallucinations were significantly more com-
mon in A-MCI (7.6%) and M-MCI (8.8%) than N-MCI
(2.4%) which contradicts the findings of a clinical study
of 120 subjects [21] in which hallucinations were more
prevalent in those with N-MCI (6 of 26) than in A-MCI/
M-MCI (4 of 94). In the current population-based study
the numbers with amnestic and non-amnestic subtypes
are more equal with 204 A-MCI/M-MCI and 185 N-MCI
which suggests that N-MCI may be under-represented in
the clinic and that individuals with N-MCI presenting to
clinical services may not be representative and are those
with more behavioural and psychological problems.
Lower general cognitive function has been consistently
associated with a higher prevalence of behavioural and
psychological symptoms in population based studies of
mild to moderate dementia [4,22] and in MCI [23]. In
the present study most symptoms were more prevalent
in those with low MMSE scores. In multivariate analysis
the risk of apathy, persecution and misidentification was
significantly increased in persons with a lower MMSE
score after adjustment for subjective memory complaints
and objective memory impairment. The risk of anxiety
was associated with a higher MMSE score.
Correlates of behavioural and psychological symptoms
In univariate analyses, being over 75 years of age had lit-
tle effect on symptom prevalence. However, in multi-
variate analyses after adjusting for cognitive function
younger participants had a significantly increased risk of
depression, feelings of persecution and agitated beha-
viour, echoing previous findings in dementia [4]. Female
subjects were significantly more likely to report depres-
sion in common with previous findings [24] while con-
trary to a previous study of 214 MCI patients we found
that men were more likely to report apathy [25], this
difference possibly owing to cross study differences in
the assessment of apathy.
In those with vascular disease the onset of cognitive
impairments may signify early vascular or mixed demen-
tia, with potentially a different profile of behavioural and
psychological symptoms. A review of behavioural
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symptoms in different dementia subtypes found an
increase in the risk of depression, emotional labiality,
anxiety and apathy in vascular dementia compared to
AD, while delusions, delusional misidentification, wan-
dering and restlessness were less frequent in vascular
dementia compared with Alzheimer’s disease [26]. In our
study of the population without dementia the presence of
vascular disease significantly increased the risk of depres-
sion, apathy, anxiety, irritability and sleep problems, with
these associations moderately attenuated after adjusting
for cognitive impairment. After adjustment for cognitive
impairment agitated behaviour was negatively associated
with a history of vascular disease, suggesting an associa-
tion with non-vascular sources of early cognitive change.
Consistent with previous studies [23,27-29] we
observed a positive, significant relationship between ADL
impairment and depression, apathy, anxiety, persecution,
hallucination, irritability, sleep problems and misidentifi-
cation. While the first definitions of MCI excluded those
with ADL impairments [30], more recent clinical defini-
tions are more inclusive allowing impairment in complex
or instrumental ADLs [31] although those with severe
ADL impairments may be excluded from a diagnosis.
Co-occurrence of symptoms
The relationships between some behavioural and psycho-
logical symptoms in dementia are well known [32,33],
but there are few reports of their co-occurrence in early
cognitive impairment [34]. We report a moderate statisti-
cally significant association between many pairs of symp-
toms, which remained after adjusting for cognitive and
socio-demographic factors. Factor analysis identified
three factors corresponding to misidentification and hal-
lucination; apathy, anxiety and depression; and feelings of
persecution and irritability. However, the high unique-
ness of each symptom and the significant co-occurrence
that was not represented in the factor structure indicates
that most of the variance cannot be explained by these
factors. In a previous study of the population with
dementia in MRC CFAS, similar factors but with stronger
patterns of co-occurrence were observed [4].
Conclusions
Recent reviews have demonstrated large variation in esti-
mates of the prevalence of behavioural and psychological
symptoms in MCI [6,7]. This variation can in part be
explained by different diagnostic criteria for MCI and use
of different study settings. Most symptoms are less preva-
lent in the population than in clinical samples [6]. We have
shown that behavioural and psychological symptoms are
related to many of the criteria used in inclusion and exclu-
sion criteria for MCI diagnosis. In particular, those with
subjective memory complaints were more likely to report
symptoms independently of objective measures of cognitive
function and memory impairment. Behavioural or psycho-
logical problems may precipitate contact with medical ser-
vices, which may contribute higher prevalence in tertiary
referral centres compared with the general population.
Behavioural and psychological problems are common in
dementia [4] and have become accepted as central charac-
teristics of the disorder. Behavioural and psychological
symptoms in dementia are at least as problematic for
patients and caregivers as cognitive impairments, signifi-
cantly affecting quality of life and cost of care of people
with dementia [1,2]. Furthermore, they currently offer
greater opportunities for intervention and management
than does cognitive impairment [3]. Current definitions of
MCI focus entirely on cognition and may exclude those
with psychiatric symptoms on the basis that psychiatric dis-
orders might underlie cognitive impairment which should
then not be considered an indicator of incipient Alzheimer’s
disease. Yet we have shown that many behavioural and psy-
chological symptoms are present in those with mild cogni-
tive impairments with a similar pattern of occurrence to
that seen in individuals with dementia. Behavioural and psy-
chological symptoms should be assessed as possible targets
for management in cognitively impaired older people. Sev-
eral studies in patients with MCI have shown that those
with behavioural and psychological symptoms have an
increased risk of dementia incidence and suggest that non-
cognitive symptoms should be a consideration when identi-
fying those in the earliest stages of dementia [6,7]. It
remains difficult to differentiate patients with psychological
symptoms as a consequence of early dementia from those
in whom cognitive impairment is secondary to other psy-
chological conditions. Further population-based longitudi-
nal studies are needed to establish whether behavioural and
psychological symptoms can be used alongside memory
and other cognitive impairment to improve the identifica-
tion of those at highest risk of dementia incidence.
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